Zydus Lifesciences Limited
Zydus Lifesciences Limited (ZYDUSLIFE) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals
zyduslife.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Stock price
₹1154.20
Market cap
1,16,013 Cr
Stock P/E
26.5
P/B
3.92
Dividend yield
1.0%
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023BSE balance sheet (this exchange's own filing had none for this period) | Mar 2024 | Jun 2024BSE balance sheet (this exchange's own filing had none for this period) | Sept 2024 | Dec 2024BSE balance sheet (this exchange's own filing had none for this period) | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,369 Cr | 4,505 Cr | 5,534 Cr | 6,208 Cr | 5,237 Cr | 5,269 Cr | 6,528 Cr | 6,574 Cr | 6,123 Cr | 6,865 Cr | 7,587 Cr | 8,017 Cr |
| Operating expenses (approx.) | 3,223 Cr | 3,403 Cr | 3,903 Cr | 4,124 Cr | 3,776 Cr | 3,882 Cr | 4,402 Cr | 4,485 Cr | 4,107 Cr | 5,048 Cr | 5,033 Cr | 6,088 Cr |
| EBITDA | 1,146 Cr | 1,102 Cr | 1,631 Cr | 2,084 Cr | 1,461 Cr | 1,388 Cr | 2,126 Cr | 2,089 Cr | 2,016 Cr | 1,816 Cr | 2,554 Cr | 1,929 Cr |
| OPM % | 26.2% | 24.5% | 29.5% | 33.6% | 27.9% | 26.3% | 32.6% | 31.8% | 32.9% | 26.5% | 33.7% | 24.1% |
| Other income | 54 Cr | 38 Cr | 156 Cr | 63 Cr | 68 Cr | 58 Cr | 81 Cr | 155 Cr | 109 Cr | 111 Cr | 134 Cr | 106 Cr |
| Interest | 9 Cr | 20 Cr | 35 Cr | 32 Cr | 25 Cr | 32 Cr | 77 Cr | 85 Cr | 101 Cr | 130 Cr | 123 Cr | 156 Cr |
| Depreciation | 184 Cr | 195 Cr | 205 Cr | 215 Cr | 234 Cr | 229 Cr | 238 Cr | 238 Cr | 302 Cr | 360 Cr | 508 Cr | 555 Cr |
| Profit before tax | 1,006 Cr | 953 Cr | 1,551 Cr | 1,919 Cr | 1,271 Cr | 1,184 Cr | 1,667 Cr | 1,955 Cr | 1,693 Cr | 1,411 Cr | 1,659 Cr | 1,344 Cr |
| Tax % | 22.5% | 22.4% | 20.7% | 22.7% | 29.3% | 15.2% | 25.4% | 22.2% | 26.8% | 27.5% | 19.2% | 26.3% |
| Net profit | 803 Cr | 790 Cr | 1,246 Cr | 1,483 Cr | 920 Cr | 1,026 Cr | 1,244 Cr | 1,521 Cr | 1,239 Cr | 1,023 Cr | 1,341 Cr | 990 Cr |
| EPS (₹) | ₹7.91 | ₹7.80 | ₹11.69 | ₹14.11 | ₹9.06 | ₹10.17 | ₹11.64 | ₹14.58 | ₹12.51 | ₹10.36 | ₹12.65 | ₹9.35 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020 | Mar 2021 | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 13,166 Cr | 14,253 Cr | 15,102 Cr | 15,265 Cr | 17,237 Cr | 19,547 Cr | 23,242 Cr | 27,148 Cr | Sign in for TTM |
| Operating expenses (approx.) | 10,193 Cr | 11,470 Cr | 11,761 Cr | 11,925 Cr | 13,378 Cr | 14,163 Cr | 16,183 Cr | 18,673 Cr | Sign in for TTM |
| EBITDA | 2,973 Cr | 2,783 Cr | 3,341 Cr | 3,341 Cr | 3,860 Cr | 5,384 Cr | 7,059 Cr | 8,475 Cr | Sign in for TTM |
| OPM % | 22.6% | 19.5% | 22.1% | 21.9% | 22.4% | 27.5% | 30.4% | 31.2% | Sign in for TTM |
| Other income | 201 Cr | 114 Cr | 37 Cr | 225 Cr | 187 Cr | 284 Cr | 270 Cr | 510 Cr | Sign in for TTM |
| Interest | 194 Cr | 342 Cr | 164 Cr | 127 Cr | 130 Cr | 81 Cr | 166 Cr | 439 Cr | Sign in for TTM |
| Depreciation | 599 Cr | 697 Cr | 725 Cr | 713 Cr | 723 Cr | 764 Cr | 916 Cr | 1,408 Cr | Sign in for TTM |
| Profit before tax | 2,429 Cr | 1,524 Cr | 2,332 Cr | 5,232 Cr | 2,583 Cr | 4,838 Cr | 6,085 Cr | 6,718 Cr | Sign in for TTM |
| Tax % | 21.8% | 21.0% | 6.3% | 9.8% | 22.8% | 20.2% | 23.2% | 23.7% | Sign in for TTM |
| Net profit | 1,899 Cr | 1,204 Cr | 2,185 Cr | 4,618 Cr | 2,092 Cr | 3,973 Cr | 4,673 Cr | 5,124 Cr | Sign in for TTM |
| EPS (₹) | ₹18.06 | ₹11.49 | ₹20.84 | ₹43.84 | ₹19.30 | ₹38.14 | ₹44.97 | ₹50.09 | Sign in for TTM |
| Dividend payout % | — | — | — | 8.1% | 12.8% | 15.6% | 6.5% | 21.6% | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020 | Mar 2021 | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 102 Cr | 102 Cr | 102 Cr | 102 Cr | 101 Cr | 101 Cr | 101 Cr | 101 Cr |
| Reserves | 10,284 Cr | 10,273 Cr | 12,890 Cr | 16,897 Cr | 17,415 Cr | 19,729 Cr | 23,853 Cr | 27,011 Cr |
| Borrowings | 7,147 Cr | — | — | 4,196 Cr | 1,163 Cr | 769 Cr | 3,170 Cr | 11,770 Cr |
| Other liabilities | 4,657 Cr | 13,311 Cr | 10,892 Cr | 4,546 Cr | 4,905 Cr | 6,411 Cr | 7,674 Cr | 11,055 Cr |
| Total liabilities | 23,483 Cr | 23,687 Cr | 23,885 Cr | 27,795 Cr | 25,756 Cr | 29,281 Cr | 37,202 Cr | 52,407 Cr |
| Fixed assets (net) | 5,106 Cr | — | — | 5,762 Cr | 5,697 Cr | 5,803 Cr | 6,042 Cr | 9,231 Cr |
| CWIP | 837 Cr | — | — | 661 Cr | 1,130 Cr | 1,112 Cr | 1,318 Cr | 1,166 Cr |
| Investments | 674 Cr | — | — | 3,288 Cr | 1,547 Cr | 1,221 Cr | 6,408 Cr | 7,540 Cr |
| Loans & advances | 10 Cr | — | — | 0 Cr | 0.40 Cr | 2 Cr | 77 Cr | 4 Cr |
| Inventories | 2,688 Cr | — | — | 3,719 Cr | 3,413 Cr | 3,442 Cr | 3,944 Cr | 5,628 Cr |
| Trade receivables | 3,951 Cr | — | — | 3,340 Cr | 4,417 Cr | 5,220 Cr | 4,025 Cr | 5,416 Cr |
| Cash & bank | 421 Cr | — | — | 658 Cr | 488 Cr | 413 Cr | 827 Cr | 855 Cr |
| Other assets | 9,797 Cr | 23,687 Cr | 23,885 Cr | 10,367 Cr | 9,065 Cr | 12,069 Cr | 14,561 Cr | 22,568 Cr |
| Total assets | 23,483 Cr | 23,687 Cr | 23,885 Cr | 27,795 Cr | 25,756 Cr | 29,281 Cr | 37,202 Cr | 52,407 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020 | Mar 2021 | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 2,078 Cr | 2,689 Cr | 3,228 Cr | 6,777 Cr | 2,117 Cr |
| Cash from investing | — | — | — | 1,154 Cr | 1,171 Cr | -1,475 Cr | -8,372 Cr | -8,296 Cr |
| Cash from financing | — | — | — | -868 Cr | -4,400 Cr | -1,804 Cr | 2,031 Cr | 5,997 Cr |
| Net cash flow | — | — | — | 2,373 Cr | -534 Cr | -75 Cr | 414 Cr | 28 Cr |
| Free cash flow (OCF − Capex) | — | — | — | 876 Cr | 1,658 Cr | 2,321 Cr | 5,064 Cr | -1,277 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020 | Mar 2021 | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 25.2% | 18.0% | 19.2% | 31.5% | 13.0% | 21.5% | 21.2% | 17.3% |
| ROE % | 17.8% | 11.3% | 16.4% | 26.4% | 10.0% | 0.5% | 0.6% | 17.0% |
| Debtor days | 109 | — | — | 80 | 93 | 97 | 63 | 73 |
| Inventory days | 366 | — | — | 335 | 301 | 274 | 328 | 401 |
| Days payable | 262 | — | — | 192 | 188 | 169 | 192 | 203 |
| Cash conversion cycle | 213 | — | — | 222 | 207 | 202 | 199 | 271 |
| Debt / equity | 0.69 | — | 0.00 | 0.25 | 0.07 | 0.04 | 0.13 | 0.43 |
| Current ratio | 1.16 | — | — | 1.55 | 1.81 | 2.14 | 1.89 | 1.27 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 0.17 | 0.07 | 0.33 | 1.29 |
Compare with peers
Loading peers…